title: Lentiviral-mediated RNA interference targeting stathmin1 gene in human gastric cancer cells inhibits proliferation in vitro and tumor growth in vivo.
abstract: BACKGROUND
  Gastric cancer is highly aggressive disease. Despite advances in diagnosis and therapy, the prognosis is still poor. Various genetic and molecular alterations are found in gastric cancer that underlies the malignant transformation of gastric mucosa during the multistep process of gastric cancer pathogenesis. The detailed mechanism of the gastric cancer development remains uncertain. In present study we investigated the potential role of stathmin1 gene in gastric cancer tumorigenesis and examined the usefulness of RNA interference (RNAi) targeting stathmin1 as a form of gastric cancer treatment.
  
  
  METHODS
  A lentiviral vector encoding a short hairpin RNA (shRNA) targeted against stathmin1 was constructed and transfected into the packaging cells HEK 293 T and the viral supernatant was collected to transfect MKN-45 cells. The transwell chemotaxis assay and the CCK-8 assay were used to measure migration and proliferation of tumor cells, respectively. Quantitative real-time PCR and western blotting were used to detect the expression levels of stathmin1.
  
  
  RESULTS
  Lentivirus mediated RNAi effectively reduced stathmin1 expression in gastric cells. Significant decreases in stathmin1 mRNA and protein expression were detected in gastric cells carrying lentiviral stathmin-shRNA vector and also significantly inhibited the proliferation, migration in gastric cancer cells and tumorigenicity in Xenograft Animal Models.
  
  
  CONCLUSIONS
  Our findings suggest that stathmin1 overexpression is common in gastric cancer and may play a role in its pathogenesis. Lentivirus mediated RNAi effectively reduced stathmin1 expression in gastric cells. In summary, shRNA targeting of stathmin1 can effectively inhibits human gastric cancer cell growth in vivo and may be a potential therapeutic strategy for gastric cancer.
authors.affiliation: Department of Thoracic Surgery, Provincial Hospital Affiliated to Shandong University, 250021, Shandong, China. wz620226@hotmail.com.
authors.forename: Javed
authors.initials: J
authors.lastname: Akhtar
authors.forename: Zhou
authors.initials: Z
authors.lastname: Wang
authors.forename: Zhi Ping
authors.initials: ZP
authors.lastname: Zhang
authors.forename: Ming Ming
authors.initials: MM
authors.lastname: Bi
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000235:genetics; D049109:Cell Proliferation; D015972:Gene Expression Regulation, Neoplastic; D055785:Gene Knockdown Techniques; D057809:HEK293 Cells; D006801:Humans; D016086:Lentivirus / Q000378:metabolism*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009361:Neoplasm Invasiveness; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000378:metabolism; D050777:Stathmin / Q000235:genetics* / Q000378:metabolism; D013274:Stomach Neoplasms / Q000235:genetics* / Q000473:pathology*; D014161:Transduction, Genetic; D014162:Transfection; D023041:Xenograft Model Antitumor Assays
chemical_list: D034741:RNA, Small Interfering; C493995:STMN1 protein, human; D050777:Stathmin
references.citation: Eur J Cancer. 2001 Oct;37 Suppl 8:S4-66
references.pmid: 11602373
references.citation: Genes Dev. 2001 Jan 15;15(2):188-200
references.pmid: 11157775
references.citation: Oncogene. 2013 Mar 7;32(10):1330-7
references.pmid: 22665054
references.citation: Br J Cancer. 2000 Aug;83(3):311-8
references.pmid: 10917544
references.citation: Oncogene. 2004 Aug 23;23(38):6329-40
references.pmid: 15322508
references.citation: Clin Cancer Res. 2011 May 15;17(10):3368-77
references.pmid: 21242118
references.citation: J Neural Transm Suppl. 2007;(72):43-9
references.pmid: 17982877
references.citation: PLoS One. 2013 Aug 21;8(8):e71272
references.pmid: 23990942
references.citation: Br J Cancer. 2006 Mar 13;94(5):717-23
references.pmid: 16495930
references.citation: J Neurosurg Pediatr. 2009 Jul;4(1):74-80
references.pmid: 19569914
references.citation: Cancer Res. 1996 Mar 15;56(6):1445-50
references.pmid: 8640838
references.citation: CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30
references.pmid: 16514137
references.citation: Biochem J. 1992 Oct 15;287 ( Pt 2):549-54
references.pmid: 1445213
references.citation: Br J Cancer. 2010 Feb 16;102(4):710-8
references.pmid: 20087351
references.citation: Trends Biochem Sci. 1991 Aug;16(8):301-5
references.pmid: 1957351
references.citation: Prostate. 1995 Aug;27(2):102-9
references.pmid: 7638082
references.citation: Curr Opin Oncol. 2007 Jan;19(1):50-4
references.pmid: 17133112
references.citation: Eur J Cancer. 2011 Oct;47(15):2353-63
references.pmid: 21680174
references.citation: Urology. 2009 Dec;74(6):1264-9
references.pmid: 19800106
references.citation: Hum Gene Ther. 2002 Dec 10;13(18):2197-201
references.pmid: 12542850
references.citation: Cancer. 2009 Jun 1;115(11):2453-63
references.pmid: 19322891
references.citation: J Biol Chem. 1994 Apr 8;269(14):10312-8
references.pmid: 8144611
references.citation: Proc Natl Acad Sci U S A. 2007 May 1;104(18):7564-9
references.pmid: 17452630
references.citation: Biochem Biophys Res Commun. 1991 Sep 30;179(3):1649-55
references.pmid: 1930203
references.citation: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references.pmid: 21296855
references.citation: Expert Rev Anticancer Ther. 2008 Sep;8(9):1461-70
references.pmid: 18759697
references.citation: Anat Rec (Hoboken). 2012 Dec;295(12):2114-21
references.pmid: 22961798
references.citation: ScientificWorldJournal. 2012;2012:761909
references.pmid: 22606061
references.citation: Br J Cancer. 1998 Sep;78(6):701-9
references.pmid: 9743287
references.citation: J Cancer Res Clin Oncol. 2009 Jun;135(6):837-46
references.pmid: 19034510
references.citation: Breast Cancer Res Treat. 2008 Jul;110(2):317-26
references.pmid: 17874182
references.citation: Expert Opin Ther Targets. 2011 Nov;15(11):1249-66
references.pmid: 21978024
references.citation: Methods Mol Biol. 2009;472:467-77
references.pmid: 19107449
references.citation: Adv Drug Deliv Rev. 2009 Jul 25;61(9):732-45
references.pmid: 19341774
references.citation: Mol Cell Proteomics. 2003 Feb;2(2):107-16
references.pmid: 12644570
references.citation: RNA. 2003 Apr;9(4):493-501
references.pmid: 12649500
references.citation: Cancer Genomics Proteomics. 2005 Jul-Aug;2(4):227-237
references.pmid: 31394711
references.citation: Ann Surg Oncol. 2014 Jan;21(1):315-21
references.pmid: 23975322
references.citation: Mt Sinai J Med. 2002 Oct;69(5):299-304
references.pmid: 12415323